[HTML][HTML] Clinical pharmacokinetics of gentamicin in various patient populations and consequences for optimal dosing for gram-negative infections: an updated review
CJ Hodiamont, AK van den Broek, SL de Vroom… - Clinical …, 2022 - Springer
Gentamicin is an aminoglycoside antibiotic with a small therapeutic window that is currently
used primarily as part of short-term empirical combination therapy. Gentamicin dosing …
used primarily as part of short-term empirical combination therapy. Gentamicin dosing …
[HTML][HTML] Pharmacokinetics of gentamicin in critically ill patients: pilot study evaluating the first dose
J Goncalves-Pereira, A Martins, P Povoa - Clinical microbiology and …, 2010 - Elsevier
Gentamicin is extensively used in the treatment of severe Gram-negative bacterial infections.
A loading dose of 7 mg/kg is recommended to achieve a maximum concentration (C max) …
A loading dose of 7 mg/kg is recommended to achieve a maximum concentration (C max) …
Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosing
DJ Demczar, AN Nafziger… - Antimicrobial agents and …, 1997 - Am Soc Microbiol
Two doses of gentamicin (2 and 7 mg/kg of body weight) were administered to 11 healthy
volunteers in a randomized, crossover single-dose study to compare their pharmacokinetics …
volunteers in a randomized, crossover single-dose study to compare their pharmacokinetics …
Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing
D Xuan, DP Nicolau, CH Nightingale - International journal of antimicrobial …, 2004 - Elsevier
The purpose of this study was to describe the population pharmacokinetics of gentamicin in
a group of 939 adult hospitalized patients receiving once-daily administration of gentamicin …
a group of 939 adult hospitalized patients receiving once-daily administration of gentamicin …
Gentamicin and renal function: lessons from 15 years' experience of a pharmacokinetic service for extended interval dosing of gentamicin
SM Plajer, PKL Chin, JWA Vella-Brincat… - Therapeutic drug …, 2015 - journals.lww.com
Background: Extended interval dosing (EID) of gentamicin most commonly involves dosing
every 24 hours, but patients with impaired renal function may require a longer dose interval …
every 24 hours, but patients with impaired renal function may require a longer dose interval …
Population pharmacokinetics of a single daily intramuscular dose of gentamicin in children with severe malnutrition
C Seaton, J Ignas, S Muchohi… - Journal of …, 2007 - academic.oup.com
Abstract Objectives The World Health Organization recommends that all children admitted
with severe malnutrition should routinely receive parenteral ampicillin and gentamicin; …
with severe malnutrition should routinely receive parenteral ampicillin and gentamicin; …
Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic pharmacodynamic modelling as tools to personalize gentamicin therapy
CC Llanos-Paez, S Hennig… - Journal of Antimicrobial …, 2017 - academic.oup.com
Population pharmacokinetic modelling, Monte Carlo simulation and semi-mechanistic
pharmacodynamic modelling are all tools that can be applied to personalize gentamicin …
pharmacodynamic modelling are all tools that can be applied to personalize gentamicin …
A review of population pharmacokinetic models of gentamicin in paediatric patients
M Crcek, J Zdovc, M Kerec Kos - Journal of Clinical Pharmacy …, 2019 - Wiley Online Library
What is known and objectives Gentamicin is often used for the treatment of Gram‐negative
infections. Due to pharmacokinetic variability in paediatric patients, appropriate dosing of …
infections. Due to pharmacokinetic variability in paediatric patients, appropriate dosing of …
Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysis
CJ Hodiamont, NP Juffermans, CSC Bouman… - International journal of …, 2017 - Elsevier
When treating critically ill patients with gentamicin for severe infection, peak concentrations
(C max) determine clinical efficacy and trough concentrations (C min) determine toxicity …
(C max) determine clinical efficacy and trough concentrations (C min) determine toxicity …
Gentamicin dosing strategy in patients with end-stage renal disease receiving haemodialysis: evaluation using a semi-mechanistic pharmacokinetic …
L Zhuang, Y He, H Xia, Y Liu, SKB Sy… - Journal of …, 2016 - academic.oup.com
Objectives Gentamicin is widely used in end-stage renal disease (ESRD) patients for the
treatment of infections. The goal of this study was to find the most reasonable dosing …
treatment of infections. The goal of this study was to find the most reasonable dosing …
相关搜索
- optimal dosing patient populations
- optimal dosing clinical pharmacokinetics
- clinical pharmacokinetics patient populations
- pharmacokinetics of gentamicin aminoglycoside dosing
- gentamicin in children population pharmacokinetics
- dosing optimization population pharmacokinetics
- pharmacokinetics of gentamicin high doses
- pharmacokinetic service interval dosing
- replacement therapy population pharmacokinetics
- severe malnutrition population pharmacokinetics
- hospitalized patients population pharmacokinetics